# 437; 16 C.F.R. Part 801: Premerger Notification: Reporting and Waiting Period Requirements: Notice of Proposed Rulemaking: Proposed Amendments to the Premerger Notification Rules For Determining the Reportability of A Transaction Involving the Transfer of Rights to A Patent in the Pharmaceutical Industry; Project No. P989316
Summary of Communications Placed on the Public Record Pursuant to Commission Rule 1.26(b)(5), 16 C.F.R. 1.26(b)(5) (2013) (April 3, 2013 Meeting Attended by Commissioner Wright, Three of His Attorney Advisors, Three Commission Staff Members, and Representatives of the Pharmaceutical Research and Manufacturers of America)